Alife Health’s AI embryo selection tool gains CE mark
October 24, 2025
The tool integrates with the current laboratory infrastructure, captures images of embryos and creates an AI score.
The tool integrates with the current laboratory infrastructure, captures images of embryos and creates an AI score.
The device has shown to be advantageous for individuals with neurological or orthopaedic disorders.
The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses functional dyspepsia.
Novel technology delivers enhanced image contrast and resolution for confident decisions
An endoscopy—using a fiber‐optic tube to peer inside the body and collect biopsy samples—can be an invaluable way to detect cancer of the esophagus. But sometimes, an endoscopy can miss esophageal cancer, which doesn’t get detected until weeks or months later.
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.
Randomized, controlled clinical trials are crucial for telling whether a new treatment is safe and effective. But often scientists don’t fully report the details of their trials in a way that allows other researchers to gauge how well they designed and conducted those studies.
For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.
Melbourne scientists have revealed how hydrogen is made and used in the human gut. Though infamous for making flatulence ignite, hydrogen also has a positive role supporting gut health.
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective Tregcells. These cells help ensure that the immune system doesn’t attack the body’s own tissues. The breakthroughs could usher in more personalized and targeted cell therapies for a host of autoimmune diseases.